R&D Systems™ Recombinant Human Latent TGF-beta 1 Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Product Code	Brand	Formulation	Quantity
18127290	R&D Systems™ 299-LT-005	Supplied as a 0.2μm filtered solution in PBS and Glycerol with BSA as a carrier protein.	5μg
18338947	R&D Systems™ 299-LT-025/CF
18126910	R&D Systems™ 299-LT-005/CF	Supplied as a 0.2μm filtered solution in PBS and Glycerol.	5μg
18117560	R&D Systems™ 299-LT-025	Supplied as a 0.2μm filtered solution in PBS and Glycerol with BSA as a carrier protein.	25μg

Description

The Recombinant Human Latent TGF-beta 1 Protein is derived from CHO. The Recombinant Human Latent TGF-beta 1 Protein has been validated for the following applications: Bioactivity.

Specifications

• Gene ID (Entrez): 7040
• Name: Latent TGF-beta 1
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after opening. 3 months, ≤ -20° C under sterile conditions after opening.
• Gene Alias: CEDLAP, DPD1, latency-associated peptide, TGF beta1, TGFB, TGFB1, TGFbeta, TGFbeta 1, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1
• Recombinant: Recombinant

• Molecular Weight (g/mol): Observed Molecular Wt: 40-43kDa & 12kDa, reducing conditions 80-90kDa, non-reducing conditions, Predicted Molecular Wt.: 41.3kDa (monomer)
• Source: Chinese Hamster Ovary cell line,CHO-derived human TGF-beta 1 protein Leu30-Ser390
• Endotoxin Concentration: <1.0 EU per 1μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Purity or Quality Grade: 97%, by SDS-PAGE under reducing conditions and visualized by silver stain.